What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - COMMON STOCK in Q2 2014?

50 institutional investors reported AKBA - Akebia Therapeutics, Inc. - COMMON STOCK for Q2 2014. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)

CUSIP: 00972D105

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / COMMON STOCK
Shares outstanding: 270,093,163
Total 13F shares: 7,180,472
Share change: +7,076,001
Total reported value: $199,536,396
Price per share: $27.79
Number of holders: 50
Value change: +$197,487,337
Number of buys: 49
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GILDER GAGNON HOWE & CO LLC	13F	Company	0.02%	62,380	$1,220,000	—	31 Mar 2014	13F
Laurion Capital Management LP	13F	Company	0.01%	22,975	$449,000	—	31 Mar 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	18,448	$361,000	—	31 Mar 2014	13F

Institutional Holders of Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) as of Q2 2014

As of 30 Jun 2014, Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,180,472 shares. The largest 10 holders included Novo A/S, FMR LLC, HealthCor Management, L.P., RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, STIFEL FINANCIAL CORP, Cormorant Asset Management, LLC, MORGAN STANLEY, BlackRock Fund Advisors, and JENNISON ASSOCIATES LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders

Q2 2014 holders

Holder diff

Investor	Q1 2014 Shares	Q2 2014 Shares	Share Diff	Share Chg %	Q1 2014 Value $	Q2 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.